JPRN-jRCTs021180003已完成4 期
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese Patients - Ranibizumab for Exudative Age-Related Macular Degeneration
Saito Masaaki0 个研究点目标入组 70 人开始时间: 2019年3月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
70 eyes were enrolled in this study. However, we reluctantly abandoned for evaluating the efficacy for the mean change in best-corrected visual acuity from baseline at Month 12 due to discontinuance the study. But we made confirmmation the safety in this study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50age 至 ot applicable（—）
- 性别
- All
入选标准
- •1) naive neovascular AMD with older than 50 years and acceptance of this study
- •2) typical AMD
排除标准
- •1) previous treatment for AMD
- •2) polypoidal choroidal vasculopathy
- •3) retinal angiomatous proliferation
- •4) diabetic maculopathy, retinal vascular occlusion, or idiopathic macular telangiectasia
研究者
相似试验
已完成
不适用
Intra-retinal arterial fibrinolysisCentral retinal artery occlusionJPRN-jRCTs031180441Kadonosono Kazuaki3
已完成
2 期
Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)Proliferative Diabetic RetinopathyVitreous HemorrhageNCT00996437Jaeb Center for Health Research261
已完成
4 期
Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot StudyRetinal NeovascularisationDiabetic RetinopathyNCT01306981Moorfields Eye Hospital NHS Foundation Trust30
尚未招募
4 期
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese PatientsExudative Age-Related Macular DegenerationJPRN-UMIN000027799Akita University Department of Ophthalmology50
已完成
3 期
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaDiabetic Macular EdemaNCT01627249Jaeb Center for Health Research660